>>Description of the research protocol "Metformine radiothérapie"

Phase II trial of metformin combined with preoperative chemoradiation for rectal cancer: towards an organ preserving approach
Phase II study| Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Hémato-onco
Brugmann identifier : Metformine radiothérapie
EudraCT identifier : 2017-000814-50


Involved department : Hemato-oncology
Principal investigator : Lecomte/Chapiro/De Ridder
Sponsor : UZ Brussel
Contact : Clinical Research Unit

>This protocol was approved by the UZ Brussel ethics committee.